Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinoma.

Yi Tan,Shukui Qin,Xin Hou,Xiujuan Qian,Jun Xia,Yumei Li,Rui Wang,Changjie Chen,Qingling Yang,Lucio Miele,Qiong Wu,Zhiwei Wang
DOI: https://doi.org/10.2174/138161282001140113125143
IF: 3.31
2014-01-01
Current Pharmaceutical Design
Abstract:Background: Hepatocellular carcinoma ( HCC) has high mortality partly due to acquiring drug resistance during chemotherapy treatment. Therefore, it is necessary to explore the underlying mechanism of drug resistance. Methods: We used 2-DE and MALDI-TOF-MS analysis to explore the possible molecular insight into 5-FU resistance in HCC. The differentially expressed proteins were validated by Western blot analysis. Results: We identified 102 unique proteins including p16, maspin, PRDX6, PSMB7, MYL6, PHB, and HSP27 with alteration in SMMC-7721/5-FU. Furthermore, down-regulation of PRDX6 and PSMB7 enhanced SMMC-7721/5-FU cells to 5-FU sensitivity. Conclusions: Our study suggests that targeting drug resistant genes such as PRDX6 and PSMB7 could be a novel approach to overcome 5-FU resistance in HCC cells.
What problem does this paper attempt to address?